List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 9 studies with search of: lymphoma OR CLL | abt-263
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer
Conditions: Lymphoma;   Chronic Lymphocytic Leukemia;   Solid Tumors
Intervention: Drug: ABT-263
2 Recruiting A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
Conditions: Lymphoma;   Chronic Lymphocytic Leukemia;   Solid Tumors
Interventions: Drug: ABT-263;   Drug: erlotinib;   Drug: irinotecan
3 Recruiting A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263
Conditions: Lymphoma;   Chronic Lymphocytic Leukemia;   Solid Tumors
Interventions: Drug: ABT-263;   Drug: Ketoconazole
4 Active, not recruiting Oral Bioavailability and Pharmacokinetics (PK) Study of the Capsule Formulation of ABT-263 in Cancer
Conditions: Chronic Lymphocytic Leukemia;   Lymphomas;   Leukemias
Intervention: Drug: ABT-263
5 Recruiting A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Conditions: Lymphoma;   Lymphoma, Follicular
Intervention: Drug: ABT-263
6 Not yet recruiting Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
Condition: B-cell Chronic Lymphocytic Leukemia
Intervention: Drug: ABT-263
7 Completed Pharmacokinetics of Liquid vs. Capsule Form of ABT-263
Conditions: Non-Hodgkins Lymphoma;   Lung Cancer;   Colorectal Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: ABT-263
8 Recruiting Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: ABT-263;   Drug: FCR;   Drug: BR
9 Recruiting A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: ABT-263

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options